好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Erythrocytapheresis: An emerging treatment option for cerebral fat embolism from hemoglobinopathy related bone marrow necrosis.
Cerebrovascular Disease and Interventional Neurology
P4 - Poster Session 4 (5:30 PM-6:30 PM)
3-007

To outline a rare case of cerebral fat embolism syndrome (FES), from bone marrow necrosis during a sickle cell-thalassemia crisis, that was successfully treated with erythrocytapheresis. 

 

 

Cerebral FES presents with multiple micro-infarcts from occlusion of arterioles by fat emboli and micro-hemorrhages from fatty acid related cytotoxicity. Sickle cell disease crisis can cause avascular necrosis within the bone marrow precipitating FES. Erythrocytapheresis was shown to improve mortality in recent literature. 
Case report

27 year old woman with heterozygous HbS-beta thalassemia disease and prior history of acute chest syndrome was found down at home unresponsive. On exam, she was obtunded with intact brain stem reflexes and symmetric withdrawal. Lab work suggested active hemolysis and peripheral smear showed numerous nucleated RBCs. Toxicology and infectious work-up was unrevealing including lumbar puncture. EEG showed generalized slowing and initial MRI brain revealed restricted diffusion symmetrically in deep grey matter. Repeat MRI brain performed 3 days later due to persistent coma showed widespread micro-infarcts and micro-hemorrhages in a characteristic “starfield” pattern. CT shoulder showed right humerus head sclerosis. Despite absence of cutaneous or pulmonary features, her coma with no other explanation along with peripheral smear and imaging pattern, raised concern for isolated cerebral fat embolism. Bone marrow biopsy was performed and she immediately underwent exchange transfusion with rapid improvement in her mental status within 48 hours. Bone marrow biopsy subsequently confirmed avascular osteonecrosis.

Our case is a unique amalgam of many rarities including, isolated cerebral FES without pulmonary or cutaneous features, non-traumatic bone marrow necrosis from hemoglobinopathy crisis as the precipitant for FES and demonstration of erythrocytapheresis as a safe and successful treatment option in FES. This hopefully adds to the growing literature on the benefits of early erythrocytapheresis in hemoglobinopathies, not just in vaso-occusive crisis related strokes, but also in FES from avascular bone necrosis.  

Authors/Disclosures
Areeba Siddiqui, MD (Southwest Medical/Optum Care)
PRESENTER
Dr. Siddiqui has nothing to disclose.
Aparna Vaddiparti, MD (UAB Medicine, Department of Neurology, Division of Epilepsy) Dr. Vaddiparti has nothing to disclose.
Sanjay Mittal, MD (Geisinger Medical Center) Dr. Mittal has nothing to disclose.